Published: Sep, 2018

The global pharmacovigilance market is anticipated to rise in terms of competition due to entrance of new players in the market. According to a report by Transparency Market Research, the global pharmacovigilance market is highly fragmented in nature. This nature of the market is attributed to presence of various established players and startups entering the market. The profitable prospects that the market will be attaining in near future is encouraging multiple players from contract research organizations (CROs) and business process outsourcing (BPO) to engage in the market. These players are expected to collaborate and make strategic partnerships with various pharmaceutical companies. Some of the leading companies operating in the global pharmacovigilance market are Accenture Plc., Cognizant Technology Solutions, Bristol-Myers Squibb, and Covance Inc.

The global pharmacovigilance market is expected to rise at a healthy CAGR of 14.20% during the forecast period of 2014 to 2020. The global pharmacovigilance market is expected to attain a valuation of US$6.1 bn by the end of 2020. The drug development segment of pharmacovigilance is led by phase IV or post marketing surveillance as it has contributed the largest in shares in the previous years. Geographically, North America is leading the pharmacovigilance market by consuming larger shares in the market.

Strict Health Regulations to Provide Lucrative Market Growth

The global pharmacovigilance market is expected to rise significantly due to compulsory pharmacovigilance activities that are being rigorously implemented. These mandatory activities are helping in managing high risk medicines. Rise in healthcare sector leading of stringent healthcare regulations is anticipated to support the market growth. Increased number of clinical trials are another reason boosting the global market. The rise in death rates due to adverse effects of drug reactions is one of the major factors for the rise in demand for global pharmacovigilance market. Rising awareness among patients regarding the safety of medicinal products are boosting the market growth.

The global market is primarily driven due to rising awareness about the efficacy and safety of drugs among worldwide population. This has created massive demand for safer practices in medicines. The market in emerging as well as developed economies are gathering immense momentum due to rising support from governments to open pharmacovigilance centers. Strict implementation of post market monitoring mechanisms is encouraging government agencies to set up effective drug regulation system. Therefore, efforts from several pharmacovigilance centers, healthcare providers, and governmental agencies will potentially boost the global pharmacovigilance market. The increased outsourcing of pharmacovigilance services by pharmaceutical companies to CRO’s along with rising trend of contract outsourcing services are other major factors boosting the global market.

Lack of Technologically Advanced Infrastructure to Restrain Market Growth

The global pharmacovigilance market is expected to face certain restrains that might hamper the growth of the market during the forecast period. Unavailability of skilled labor in various emerging economies is one of the major reason restraining the market. Lack of information or information obtained through internet can lead to serious damage thus affecting the market. High substantial risk of data theft in pharmacovigilance methods and processes also holds potential to adversely affect the market during the forecast period.

The information in this review is based on the findings of a report by Transparency Market Research, titled “Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020.”

The global pharmacovigilance market is segmented based on:

Drug Development

  • Preclinical Studies
  • Phase I
  • Phase II
  • Phase III
  • Phase IV or Post Marketing Surveillance 

Type of Method 

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Type of Service

  • In-house
  • Contract Outsourcing


  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453